Koos Boeve

140 Chapter 7 interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 2006 Mar 15;66(6):3034-3043. 28. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009 Jun;28(1- 2):15-33. 29. Schuuring E, Verhoeven E, Litvinov S, Michalides RJ. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell- substratum contact sites. Mol Cell Biol 1993 May;13(5):2891-2898. 30. van Damme H, Brok H, Schuuring- Scholtes E, Schuuring E. The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification. J Biol Chem 1997 Mar 14;272(11):7374-7380. 31. Rothschild BL, Shim AH, Ammer AG, Kelley LC, Irby KB, Head JA, et al. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 2006 Aug 15;66(16):8017-8025. 32. Ramos-Garcia P, Gonzalez-Moles MA, Ayen A, Gonzalez-Ruiz L, Ruiz-Avila I, Gil-Montoya JA. Prognostic and clinicopathological significance of CTTN/ cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Head Neck 2019 Jun;41(6):1963-1978. 33. Larsen SR, Johansen J, Sorensen JA, Krogdahl A. The prognostic significance of histological features in oral squamous cell carcinoma. J Oral Pathol Med 2009 Sep;38(8):657-662. 34. Woolgar JA, Beirne JC, Vaughan ED, Lewis- Jones HG, Scott J, Brown JS. Correlation of histopathologic findings with clinical and radiologic assessments of cervical lymph- node metastases in oral cancer. Int J Oral Maxillofac Surg 1995 Feb;24(1 Pt 1):30-37.